Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral Vector Vaccines against Bluetongue Virus

25 Dec 2020

Abstract excerpt

Bluetongue virus (BTV), the prototype member of the genus Orbivirus (family Reoviridae), is the causative agent of an important livestock disease, bluetongue (BT), which is transmitted via biting midges of the genus Culicoides. To date, up to 29 serotypes of BTV have been described, which are classified as classical (BTV 1–24) or atypical (serotypes 25–27), and its distribution has been expanding since 1998, with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Vector-Borne Animal Diseases
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33375723
DOI: 10.3390/microorganisms9010042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral Vector Vaccines against Bluetongue VirusPMID 33375723Read ↗

Bluetongue virus: virology, pathogenesis and immunitySemantic proximity Read ↗

Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.Semantic proximity Read ↗

Rapid Generation of Replication-Deficient Monovalent and Multivalent Vaccines for Bluetongue Virus: Protection against Virulent Virus Challenge in Cattle and SheepSemantic proximity Read ↗

Development and Evaluation of a Novel Vaccines against Bluetongue Virus Serotype 4 (BTV4)Semantic proximity Read ↗

Vaccination as a Strategy to Prevent Bluetongue Virus Vertical TransmissionSemantic proximity Read ↗

Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue VirusSemantic proximity Read ↗

Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus VaccinesSemantic proximity Read ↗

Vaccination With Recombinant Adenoviruses Expressing the Bluetongue Virus Subunits VP7 and VP2 Provides Protection Against Heterologous Virus ChallengeSemantic proximity Read ↗

Bluetongue Virus: From BTV-1 to BTV-27.Semantic proximity Read ↗

Bluetongue Viruses Based on Modified-Live Vaccine Serotype 6 with Exchanged Outer Shell Proteins Confer Full Protection in Sheep against Virulent BTV8Semantic proximity Read ↗

A Synthetic Biology Approach for a Vaccine Platform against Known and Newly Emerging Serotypes of Bluetongue VirusSemantic proximity Read ↗

The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.